Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...
Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the ...
NBC Los Angeles on MSN11h
FDA weighs in on diet drug shortage, creating more confusion about compoundingThe Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients in ...
ThePrint on MSN6d
Ozempic on steroids? Successor that could cut down weight in half the time coming soonWhile Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
Research suggests that there may be safer ways of supressing your appetite without resorting to weight-loss drugs.
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
The global weight loss and obesity management market is set to experience remarkable expansion in the coming decade. With new ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback